Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
2002 2
2003 4
2004 2
2005 6
2006 6
2007 4
2008 1
2009 4
2010 1
2011 6
2012 10
2013 4
2014 3
2015 11
2016 9
2017 5
2018 4
2019 10
2020 14
2021 10
2022 17
2023 17
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Free article. Clinical Trial.
Reply.
Vandenborght LE, Enaud R, Urien C, Coron N, Girodet PO, Ferreira S, Berger P, Delhaes L. Vandenborght LE, et al. Among authors: berger p. J Allergy Clin Immunol. 2021 Feb;147(2):779-780. doi: 10.1016/j.jaci.2020.10.021. Epub 2020 Dec 1. J Allergy Clin Immunol. 2021. PMID: 33276993 No abstract available.
The gut-lung axis in the CFTR modulator era.
Lussac-Sorton F, Charpentier É, Imbert S, Lefranc M, Bui S, Fayon M, Berger P, Enaud R, Delhaes L. Lussac-Sorton F, et al. Among authors: berger p. Front Cell Infect Microbiol. 2023 Sep 15;13:1271117. doi: 10.3389/fcimb.2023.1271117. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37780857 Free PMC article. Review.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Unravelling the effects of omalizumab on fibrocytes.
Berger P, Dupin I. Berger P, et al. Respirology. 2021 Sep;26(9):825-827. doi: 10.1111/resp.14115. Epub 2021 Jul 26. Respirology. 2021. PMID: 34312947 Free article. No abstract available.
Reply.
Dupin I, Girodet PO, Berger P. Dupin I, et al. Among authors: berger p. J Allergy Clin Immunol. 2016 May;137(5):1626. doi: 10.1016/j.jaci.2016.01.022. Epub 2016 Mar 22. J Allergy Clin Immunol. 2016. PMID: 27012640 No abstract available.
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19.
Zysman M, Asselineau J, Saut O, Frison E, Oranger M, Maurac A, Charriot J, Achkir R, Regueme S, Klein E, Bommart S, Bourdin A, Dournes G, Casteigt J, Blum A, Ferretti G, Degano B, Thiébaut R, Chabot F, Berger P, Laurent F, Benlala I. Zysman M, et al. Among authors: berger p. Eur Radiol. 2023 Dec;33(12):9262-9274. doi: 10.1007/s00330-023-09759-x. Epub 2023 Jul 5. Eur Radiol. 2023. PMID: 37405504 Free PMC article.
The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis.
Enaud R, Vandenborght LE, Coron N, Bazin T, Prevel R, Schaeverbeke T, Berger P, Fayon M, Lamireau T, Delhaes L. Enaud R, et al. Among authors: berger p. Microorganisms. 2018 Mar 9;6(1):22. doi: 10.3390/microorganisms6010022. Microorganisms. 2018. PMID: 29522426 Free PMC article. Review.
136 results